MARLBOROUGH, Mass., CardioFocus, Inc., a medical device company developing the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), the most common cardiac ...
MARLBOROUGH, Mass., CardioFocus, Inc. today announced that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its HeartLight® Endoscopic Ablation System for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback